Astellas Pharma Inc.
4503Pharmaceuticals
¥2,513.00+0.48%As of Oct 29vs prior close
- Market cap
- $28.5B
- P/E (TTM)
- 12.3×
- P/E (FY1)
- 11.4×
- From 52W high
- −3.80%
- EPS (LTM)
- ¥206.83
- Revenue (LTM)
- ¥2.3T
- Net margin
- 16.05%
- Dividend yield
- 3.14%
Nomior Score
70
Steady ProfileTop 10% of the scored universe
Growth37
Quality66
Value63
Momentum86
Resilience58
Growth
+12.10%revenue a year over 3 fiscal years
YE23 ¥1.5TLTM ¥2.3T
Connections
Revenue to profitYE26
14% of revenue became net profit, up 11 pts on a year.